Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Anti-complement effects of lactoferrin-derived peptides.

Ørjan Samuelsen1, Hanne H Haukland, Hilde Ulvatne

  • 1Department of Medical Microbiology, University Hospital of North Norway, P.O. Box 56, N-9038 Tromsø, Norway. orjan.samuelsen@unn.no

FEMS Immunology and Medical Microbiology
|May 18, 2004
PubMed
Summary

Antimicrobial peptides from lactoferrin, specifically lactoferricin H and B, inhibit the classical complement pathway. These peptides show potential beyond their known antimicrobial effects, impacting immune responses.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ongoing multi-country outbreak of carbapenem-resistant <i>Enterobacter hormaechei</i> ST1344 carrying <i>bla</i> <sub>NDM-5</sub> in the European Union/European Economic Area, March 2025 to April 2026.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2026
Same author

The role of whole genome sequencing in antimicrobial susceptibility prediction of bacteria: 2025 update from the European Committee on Antimicrobial Susceptibility Testing Subcommittee.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2026
Same author

Identification of transporter-dependent capsular loci associated with the invasive potential of Escherichia coli.

Nature microbiology·2026
Same author

A One Health study of <i>Klebsiella pneumoniae</i> species complex plasmids shows a highly diverse and ecologically adaptable plasmidome.

Microbial genomics·2026
Same author

Sequence type and strain-level detection of <i>Klebsiella pneumoniae</i> in culture-enriched bacterial metagenomes: comparative performance of mSWEEP and StrainGE bioinformatic tools.

Microbial genomics·2026
Same author

Machine learning-based lineage prediction from antimicrobial susceptibility testing phenotypes for <i>Escherichia coli</i> sequence type 131 clade C surveillance across infection types.

Microbial genomics·2026

Area of Science:

  • Immunology
  • Biochemistry
  • Microbiology

Background:

  • Lactoferrin is a key biological molecule involved in immune functions, including inflammation modulation, iron metabolism, and antimicrobial defense.
  • Lactoferrin is known to inhibit the classical complement pathway, a crucial part of the innate immune system.

Purpose of the Study:

  • To investigate the effect of N-terminal lactoferrin-derived peptides, lactoferricin H and lactoferricin B, on the classical and alternative complement pathways.
  • To determine if these peptides possess inhibitory effects on complement activation beyond their antimicrobial properties.

Main Methods:

  • Assessing the inhibition of the classical complement pathway by lactoferricin H and B.
  • Evaluating the effect of these peptides on the alternative complement pathway using an AP50 assay.

Related Experiment Videos

  • Testing the impact of lactoferricin B on serum's ability to inhibit Escherichia coli growth.

    • Main Results:

    • Both lactoferricin H and lactoferricin B demonstrated inhibition of the classical complement pathway.
    • No significant inhibitory effect was observed for these peptides on the alternative complement pathway.
    • Lactoferricin B exhibited a concentration-dependent reduction in serum's inhibitory activity against Escherichia coli.

    Conclusions:

    • The N-terminal region of lactoferrin is critical for its complement activation inhibitory function.
    • Lactoferricin peptides possess significant biological activities beyond their antimicrobial effects, particularly in modulating immune responses.
    • These findings highlight lactoferricin peptides as potential therapeutic agents targeting complement-mediated inflammation.